Companies›Healthcare›Healthcare›Healthcare Services
NSE:NEPHROPLUS

NEPHROCARE HEALTH SERV L

Healthcare › Healthcare Services·NIFTY MICROCAP 250NIFTY SMALLCAP 500NIFTY TOTAL MARKET
₹625.10
at close · 27 Oct 2026
▲ 23.05 (+3.83%)

Latest filings

Next results: Tue, 3 Nov · Financial Results
  1. Subsidiary to acquire dialysis centre assets in Philippines · Strategic Transactions
  2. Q2 FY27 earnings call scheduled for November 4, 2026 · Board & Shareholder Meetings
  3. Board meeting on Nov 3 to consider Q2 and H1 FY26 results · Results
All filings ↓
Ask Nexa about NEPHROCARE HEALTH SERV L

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Runs a network of standalone dialysis clinics delivering chronic outpatient kidney care, with the core business being the same procedure replicated across geographies. The company operates both own clinics and clinics under public-private partnership contracts with state governments such as Uttarakhand and Andhra Pradesh. Beyond India, it has entered the Philippines, Uzbekistan and is in the investment phase in Saudi Arabia, where a Ministry of Health dialysis tender is at the expression-of-interest stage. International markets command materially higher per-treatment prices than India, and the company is rolling up unorganised clinic operators in those geographies. On costs, materials (consumables such as dialyzers and blood lines) are the largest line at 22.7% of revenue, with employees at 17.2%; depreciation runs at 9.1% and capex at 11.9% of revenue, consistent with an asset-heavy clinic model.

Operating scale
Clinics
524 clinics across 5 countriesFY26
Active patients (guests)
37,000FY26
Annual treatments
38.4 lakhFY26
Revenue per treatment
₹2,598FY26
International revenue mix
42%FY26
Philippines unorganised clinic long tail
600+ clinicsFY26
Who pays it
End-stage renal disease patients on chronic outpatient dialysis, reimbursed via government schemes (PhilHealth in Philippines), insurance and out-of-pocket payments
Biggest cost
Dialysis consumables such as dialyzers and blood lines, at 22.7% of revenue
Kind of business
Asset-heavy, fixed-capacity chronic care delivery with multi-country roll-up model
Where it sits
India's and Asia's largest dialysis network by volume; described as the world's fifth largest
Market Cap
₹6,272 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
13.7%▲
ROCE (FY26)
ROE 6.9% · margin 25.2%
Leverage
0.07·
Debt / Equity · low
Net cash ₹44 Cr
Moves on a normal day
1.45%·
Median daily move
Last 210 sessions · the yardstick for filing-day moves
Where it sits among 29 Healthcare Service Provider peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#20/25
P/B#16/24
ROCE#11/29
ROE#12/24
Debt / Equity#13/23
EBITDA margin#13/24

Scorecard

Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice

Strengths
Returns on capital 13.7%
#11 of 29 in Healthcare Service Provider on the latest reported figures
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

NEPHROPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from NEPHROCARE HEALTH SERV L's filed financials and exchange disclosures

What does NEPHROCARE HEALTH SERV L do?

NEPHROCARE HEALTH SERV L is a Healthcare Services company listed on NSE and BSE, trading under the symbol NEPHROPLUS.

Does NEPHROCARE HEALTH SERV L pay a dividend?

Not in the latest reported year — NEPHROCARE HEALTH SERV L's dividend payout for FY26 was nil.

Is NEPHROCARE HEALTH SERV L debt-free?

On a net basis, yes. It reported borrowings of ₹80 Cr on its 31 Mar 2026 balance sheet, but holds ₹44 Cr more cash than debt.

How much does the NEPHROCARE HEALTH SERV L share price move in a day?

On a typical session NEPHROCARE HEALTH SERV L moves 1.45% — that is the median absolute close-to-close move across its last 210 trading days. MarketPing measures each filing's price reaction against it.

When are NEPHROCARE HEALTH SERV L's next results?

Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track NEPHROCARE HEALTH SERV L's announcements?

Every NSE and BSE filing by NEPHROCARE HEALTH SERV L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.